In multiple cellular PD models, TSG was found to enhance cell viability and inhibit cell apoptosis and ROS production by modulating the JNK, p38, and PI3K-AKT signaling pathway in vitro [187–190] (Figure 3). This evidence concerns the gene MAPK8 and Parkinson disease.